论文信息 - Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A. - 字舞流文

Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A.

E. Winer | S. Loi | D. Cescon | V. Karantza | H. Rugo | H. Iwata | S. Adams | G. Curigliano | M. Campone | R. Nanda | D. Toppmeyer | J. O’Shaughnessy | A. Awada | P. Schmid | S. Paluch-Shimon | J. Cortés | R. Hui | D. Card | D. Loirat | J. Zhao